Achari Ventures Holdings Corp. I: Nasdaq/NYSE listing notice — Achari Ventures receives Nasdaq deficiency notice for market value of publicly held shares below $15M

Achari Ventures Holdings Corp. I

Nasdaq notified Achari on Feb 24, 2023 that its Market Value of Publicly Held Shares fell below the $15M minimum required by Listing Rule 5450(b)(2)(C).
Company has 180 calendar days, until August 23, 2023, to regain compliance by closing at $15M or more for 10 consecutive business days.
Achari is also evaluating a transfer of its securities to The Nasdaq Capital Market as an alternative remedy.
The deficiency notice does not currently affect the listing or trading of AVHIU, AVHI, or AVHIW on Nasdaq.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Achari Ventures Holdings Corp. I received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(C)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: market value
Rules: 5450(b)(2)(C)

Exact text from the filing

February 24, 2023, Achari Ventures Holdings Corp. I, a Delaware company (the “ Company ”) received a letter (the “ Letter ”) from the Nasdaq Listing Qualifications department of Nasdaq Global Market (“ Nasdaq ”) indicating that the Company was not in compliance with Listing Rule 5450(b)(2)(C), requiring a “Market Value” of “Publicly Held Shares” of at least $15 million. The Letter is only a notification of deficiency, not of imminent delisting, and has no current effect on the listing or trading of the Company’s securities on Nasdaq. The Letter states that the Company has 180 calendar days to

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001193125-23-056433

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.